Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis.

Gills J, Moret R, Zhang X, Nelson J, Maresh G, Hellmers L, Canter D, Hudson M, Halat S, Matrana M, Marino MP, Reiser J, Shuh M, Laborde E, Latsis M, Talwar S, Bardot S, Li L.

Oncotarget. 2018 Aug 24;9(66):32718-32729. doi: 10.18632/oncotarget.26024. eCollection 2018 Aug 24.

2.

Negligible Oval Cell Proliferation Following Ischemia-Reperfusion Injury With and Without Partial Hepatectomy.

Tan EK, Shuh M, Francois-Vaughan H, Sanders JA, Cohen AJ.

Ochsner J. 2017 Spring;17(1):31-37.

3.

Tumor Necrosis Factor-α: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury.

Shuh M, Bohorquez H, Loss GE Jr, Cohen AJ.

Ochsner J. 2013 Spring;13(1):119-30.

4.
5.

David D. Derse, 1949-2009.

Shuh M.

Retrovirology. 2009 Dec 1;6:110. doi: 10.1186/1742-4690-6-110.

11.

A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction.

Kerins DM, Shuh M, Kunitada S, Fitzgerald GA, Fitzgerald DJ.

J Pharmacol Exp Ther. 1991 Apr;257(1):487-92.

PMID:
1708425
12.

E. coli ribosomes re-phase on retroviral frameshift signals at rates ranging from 2 to 50 percent.

Weiss RB, Dunn DM, Shuh M, Atkins JF, Gesteland RF.

New Biol. 1989 Nov;1(2):159-69.

PMID:
2562219

Supplemental Content

Support Center